Filetti, Marco
Trapani, Dario
Cortellini, Alessio
Cofini, Vincenza
Necozione, Stefano
Pinato, David James
Porzio, Giampiero
Marchetti, Paolo
Giusti, Raffaele http://orcid.org/0000-0003-4592-8868
Article History
Received: 24 February 2021
Accepted: 21 June 2021
First Online: 26 June 2021
Change Date: 23 July 2021
Change Type: Update
Change Details: Updated due to the incorrect tagging of name in the xml for David James Pinato.
Compliance with ethical standards
:
: The survey did not provide any intervention to research participants. Official approval was obtained from AIOM (Associazione Italiana di Oncologia Medica) and SICP (Società Italiana di Cure Palliative) scientific committees to share the survey questionnaire through their mailing lists.
: All participants gave their consents before completing the questionnaire.
: MF, DT, VC, SN, GP, and PM declare no competing interests. AC declare consulting/advisory board fees from Astrazeneca, MSD, Roche and BMS; speakers’ fee from Novartis, Astellas, MSD, Astrazeneca. DJP received lecture fees from ViiV Healthcare and Bayer Healthcare and travel expenses from BMS and Bayer Healthcare; consulting fees for Mina Therapeutics, EISAI, Roche, and Astrazeneca; and received research funding (to institution) from MSD and BMS. RG received speaker fees and grant consultancies from Astrazeneca, Boehringer Ingelheim, Roche, and Takeda.*Chi-square test or Fisher’s exact test.